Patents by Inventor Sara Kristen Moses

Sara Kristen Moses has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7771748
    Abstract: The present invention is directed to controlled-release (CR) oral pharmaceutical dosage forms of 5,8,14-triazatetracyclo[10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaene, 1, and pharmaceutically acceptable salts thereof, and methods of using them to reduce nicotine addiction or aiding in the cessation or lessening of tobacco use while reducing nausea as an adverse effect. The present invention also relates to an immediate-release (IR) low dosage composition having a stable formulation with uniform drug distribution and potency.
    Type: Grant
    Filed: November 20, 2002
    Date of Patent: August 10, 2010
    Assignee: Pfizer Inc
    Inventors: Mary T. Am Ende, Michael C. Roy, Scott W. Smith, Kenneth C. Waterman, Sara Kristen Moses
  • Publication number: 20030180360
    Abstract: The present invention is directed to controlled-release (CR) oral pharmaceutical dosage forms of 5,8,14-triazatetracyclo[10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaene, 1, and pharmaceutically acceptable salts thereof, and methods of using them to reduce nicotine addiction or aiding in the cessation or lessening of tobacco use while reducing nausea as an adverse effect. The present invention also relates to an immediate-release (IR) low dosage composition having a stable formulation with uniform drug distribution and potency.
    Type: Application
    Filed: November 20, 2002
    Publication date: September 25, 2003
    Applicant: Pfizer Inc.
    Inventors: Mary T. Am Ende, Michael C. Roy, Scott W. Smith, Kenneth C. Waterman, Ernest S. Quan, Sara Kristen Moses